 critic analysi neoadjuv therapi stage iiia non-smal cell lung cancer erratum Am rev respir di jun lung cancer major caus cancer mortal advanc stage iii diseas entir group non-smal cell lung cancer nsclc surgic resect opportun cure resect diseas possibl minor patient stage iiia diseas patient success surgeri system relaps common surviv complet resect preoper neoadjuv chemotherapi investig attempt bleak outcom patient stage iiia nsclc preliminari trial approach feasibl neoadjuv treatment moder toxic case possibl surgic resect instanc neoadjuv treatment patholog complet respons other tumor bulk inoper patient surgic candid latter phenomenon impact surviv unknown role neoadjuv treatment advanc lung cancer trial